Literature DB >> 20923692

The absence of VPAC2 leads to aberrant antibody production in Aspergillus fumigatus sensitized and challenged mice.

Amali E Samarasinghe1, Scott A Hoselton, Jane M Schuh.   

Abstract

Vasoactive intestinal peptide (VIP) facilitates a "pro-allergy" phenotype when signaling through its G protein-coupled receptor, VPAC(2). We have shown that VPAC(2) knock-out (KO) mice developed an allergic phenotype marked by eosinophilia and elevated serum IgE. Therefore, we hypothesized that the humoral response to allergen challenge in these mice was T(H)2 dominant similar to wild-type (WT) C57BL/6 mice. Antibody responses in WT and KO mice were measured after Aspergillus fumigatus conidia inhalation. In contrast to previous reports, basal levels of serum IgG(2a) and IgA were significantly higher in naïve VPAC(2) KO animals. Antibody availability in the serum as well as the bronchoalveolar lavage fluid after fungal challenge was dominated by the pro-inflammatory isotype IgG(2a) and the mucosal isotype, IgA. IgA localizing cells dominated in the peribronchovascular areas of allergic KO mice while IgE immune complexes were found in WT allergic lungs. This research shows for the first time that VPAC(2) has a significant effect on antibody regulation, in the context of allergy.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20923692      PMCID: PMC3299058          DOI: 10.1016/j.peptides.2010.09.022

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  40 in total

Review 1.  Interactions between leukotrienes and other inflammatory mediators/modulators in the microvasculature.

Authors:  P Hedqvist; N Gautam; L Lindbom
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

Review 2.  VIP and PACAP38 modulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines.

Authors:  M Delgado; E J Munoz-Elias; C Martinez; R P Gomariz; D Ganea
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

Review 3.  Vasoactive intestinal peptide mediation of development and functions of T lymphocytes.

Authors:  G Dorsam; J Voice; Y Kong; E J Goetzl
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

4.  Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor.

Authors:  J K Voice; G Dorsam; H Lee; Y Kong; E J Goetzl
Journal:  FASEB J       Date:  2001-11       Impact factor: 5.191

5.  Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide.

Authors:  E J Goetzl; J K Voice; S Shen; G Dorsam; Y Kong; K M West; C F Morrison; A J Harmar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

Review 6.  Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists.

Authors:  G F Joos; K O De Swert; R A Pauwels
Journal:  Eur J Pharmacol       Date:  2001-10-19       Impact factor: 4.432

7.  The absence of the VPAC(2) receptor does not protect mice from Aspergillus induced allergic asthma.

Authors:  A E Samarasinghe; S A Hoselton; J M Schuh
Journal:  Peptides       Date:  2010-03-11       Impact factor: 3.750

Review 8.  The role of neuroeffector mechanisms in the pathogenesis of asthma.

Authors:  G F Joos
Journal:  Curr Allergy Asthma Rep       Date:  2001-03       Impact factor: 4.806

9.  The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei.

Authors:  Anthony J Harmar; Hugh M Marston; Sanbing Shen; Christopher Spratt; Katrine M West; W John Sheward; Christine F Morrison; Julia R Dorin; Hugh D Piggins; Jean Claude Reubi; John S Kelly; Elizabeth S Maywood; Michael H Hastings
Journal:  Cell       Date:  2002-05-17       Impact factor: 41.582

Review 10.  Neurotrophins in bronchial asthma.

Authors:  H Renz
Journal:  Respir Res       Date:  2001-07-12
View more
  15 in total

Review 1.  Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.

Authors:  Mario Delgado; Doina Ganea
Journal:  Amino Acids       Date:  2011-12-03       Impact factor: 3.520

2.  μ-chain-deficient mice possess B-1 cells and produce IgG and IgE, but not IgA, following systemic sensitization and inhalational challenge in a fungal asthma model.

Authors:  Sumit Ghosh; Scott A Hoselton; Jane M Schuh
Journal:  J Immunol       Date:  2012-06-25       Impact factor: 5.422

3.  Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis.

Authors:  Emilie E Vomhof-DeKrey; Ashley R Sandy; Jarrett J Failing; Rebecca J Hermann; Scott A Hoselton; Jane M Schuh; Abby J Weldon; Kimberly J Payne; Glenn P Dorsam
Journal:  Peptides       Date:  2011-08-22       Impact factor: 3.750

Review 4.  The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases.

Authors:  D Ganea; K M Hooper; W Kong
Journal:  Acta Physiol (Oxf)       Date:  2014-12-11       Impact factor: 6.311

5.  Characterization of CD19(+)CD23(+)B2 lymphocytes in the allergic airways of BALB/c mice in response to the inhalation of Aspergillus fumigatus conidia.

Authors:  Sumit Ghosh; Scott A Hoselton; Jane M Schuh
Journal:  Open Immunol J       Date:  2012-12-28

6.  Humoral immune responses during asthma and influenza co-morbidity in mice.

Authors:  Laura A Doorley; Kim S LeMessurier; Amy R Iverson; Maneesha Palipane; Amali E Samarasinghe
Journal:  Immunobiology       Date:  2017-09-07       Impact factor: 3.144

7.  Eosinophils in fungus-associated allergic pulmonary disease.

Authors:  Sumit Ghosh; Scott A Hoselton; Glenn P Dorsam; Jane M Schuh
Journal:  Front Pharmacol       Date:  2013-02-01       Impact factor: 5.810

8.  Type 2 innate lymphoid cells control eosinophil homeostasis.

Authors:  Jesse C Nussbaum; Steven J Van Dyken; Jakob von Moltke; Laurence E Cheng; Alexander Mohapatra; Ari B Molofsky; Emily E Thornton; Matthew F Krummel; Ajay Chawla; Hong-Erh Liang; Richard M Locksley
Journal:  Nature       Date:  2013-09-15       Impact factor: 49.962

9.  Chronic features of allergic asthma are enhanced in the absence of resistin-like molecule-beta.

Authors:  Kim S LeMessurier; Maneesha Palipane; Meenakshi Tiwary; Brian Gavin; Amali E Samarasinghe
Journal:  Sci Rep       Date:  2018-05-04       Impact factor: 4.379

Review 10.  Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.

Authors:  Kalina R Atanasova; Leah R Reznikov
Journal:  Respir Res       Date:  2018-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.